MicroRNA 580 (MIR580)

MicroRNA 580 (MIR580, hsa-mir-580) is a short, non-coding RNA molecule of the microRNA class that regulates gene expression at the post-transcriptional level by binding to target mRNA, resulting in the inhibition of translation or the destabilization of the mRNA transcript[1][5]. Like other microRNAs, MIR580 is transcribed as a primary transcript (pri-miRNA) that is sequentially processed by Drosha and Dicer ribonucleases to yield a mature microRNA, which incorporates into the RNA-induced silencing complex (RISC)[1][3]. MIR580 has been associated with disease roles in various cancers, including endocrine gland and lung cancer[1]. The specific targets and biological functions of MIR580 remain incompletely characterized, but by analogy with other microRNAs, it is likely involved in regulating cell proliferation, differentiation, and survival, and may buffer gene expression against fluctuations and stressors[4][3]. Current data do not support MIR580 as a direct therapeutic target (such as a receptor, enzyme, or transporter), but microRNAs as a class are investigated for their biomarker and therapeutic potential in diverse diseases. If you need structured information for patient selection, drug interaction, or targeted therapy specifically, there is currently no evidence for drugs directly targeting MIR580 or for its use as a clinical biomarker[1][7].

Other names

hsa-mir-580MIRN580MIR580